Transcatheter technologies triggered the recent revision of the guidelines that progressively
widened the indications for the treatment of aortic stenosis. On the surgical realm, a …

Objectives New technologies for the treatment of Aortic Stenosis are evolving to minimize
risk and treat an increasingly comorbid population. The Sutureless Perceval Valve is one …

Background Paravalvular leak (PVL) after transcatheter aortic valve implantation (TAVI) is
frequent and the impact of mild PVL on outcomes remains uncertain. Our study aimed to …

Background: The management of patients with aortic valve pathologies can sometimes fall
into a “gray zone”, where the optimal treatment approach is not straightforward. The …

Objective: The goal of this manuscript is to compare clinical and echocardiographic
outcomes of patients undergoing aortic valve replacement (AVR) with Perceval sutureless …

Over the last decade, sutureless valves (Perceval, LivaNova PLC) were brought to the
market as an alternative to stented valves for patients requiring surgical aortic valve …

Paravalvular leak (PVL) after transcatheter aortic valve implantation (TAVI) is common and
reported to occur more frequently than after surgical aortic valve replacement. 1 In this …

Aortic stenosis remains the most frequently occurring valvular pathology in the elderly
population of Western countries. According to the latest guidelines, the therapeutic choice of …

Introduction: Conduction disorders following aortic valve replacement therapy (AVR), either
surgical or percutaneous, are related to a higher risk of complete atrioventricular block and …

Aim: To evaluate clinical outcomes after redo aortic valve replacement (AVR) with sutured
valves, versus valve-in-valve transcatheter aortic valve replacement (ViV-TAVR), versus …